Aravive is clinical-stage biotechnology company focused on developing therapies that target survival pathways for both advanced solid tumors as well as hematologic malignancies. The company's primary therapeutic focus is the GAS6-AXL pathway, where AXL receptor signaling plays a role in multiple types of malignancies by promoting metastasis, cancer cell survival, resistance to treatments, and immune suppression. The U.S. Food and Drug Administration, designated as a Fast Track development program the investigation of the company's primary development candidate, Aravive-S6-500, for platinum-resistant recurrent ovarian cancer.
  • TickerARAV
  • ISINUS03890D1081
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for ARAV

ValuEngine Rating and Forecast Report for ARAV

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for ARAV

ValuEngine Rating and Forecast Report for ARAV

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Matthew Barcus
  • Robert Driscoll

ESMO 2019 Roundup for Covered Companies

David Nierengarten ...
  • Jeffrey La Rosa
  • Matthew Barcus

ARAV Arrives at ESMO with a Bang

ValuEngine Rating and Forecast Report for ARAV

ValuEngine Rating and Forecast Report for ARAV

ValuEngine Rating and Forecast Report for ARAV

ValuEngine Rating and Forecast Report for ARAV

ValuEngine Rating and Forecast Report for ARAV

ValuEngine Rating and Forecast Report for ARAV

ValuEngine Rating and Forecast Report for ARAV

ValuEngine Rating and Forecast Report for ARAV

ValuEngine Rating and Forecast Report for ARAV

ValuEngine Rating and Forecast Report for ARAV

ResearchPool Subscriptions

Get the most out of your insights

Get in touch